Shufen Zhang Selected Research

Shufen Zhang Research Topics

Disease

22	Neoplasms (Cancer) 12/2023 - 01/2015
5	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2018
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2016
5	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2016
4	Breast Neoplasms (Breast Cancer) 02/2024 - 07/2022
4	Postpartum Depression (Post-Natal Depression) 01/2023 - 01/2020
3	Hypoxia (Hypoxemia) 02/2024 - 01/2022
2	Cognitive Dysfunction 01/2023 - 01/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2021
2	Glioma (Gliomas) 01/2020 - 05/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 11/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 06/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024
1	Ischemia 01/2024
1	Myocardial Infarction 01/2024
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024
1	Bites and Stings (Sting) 12/2023
1	Squamous Intraepithelial Lesions 10/2023
1	Papillomavirus Infections 10/2023
1	Vascular Tissue Neoplasms 10/2023
1	Colorectal Neoplasms (Colorectal Cancer) 09/2023
1	Adenocarcinoma of Lung 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Memory Disorders (Memory Loss) 01/2022
1	Hyperphosphatemia 04/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Ischemic Stroke 01/2021
1	Gliosis 01/2021
1	Weight Loss (Weight Reduction) 05/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 01/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2016
4	Long Noncoding RNAIBA 01/2024 - 01/2018
4	MicellesIBA 12/2023 - 05/2022
4	Tuberculin (PPD)IBA 01/2023 - 01/2020
4	Hyaluronic Acid (Hyaluronan)IBA 07/2022 - 01/2021
4	LipidsIBA 05/2021 - 12/2014
3	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2020
3	ChitosanIBA 12/2023 - 10/2021
3	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2015
3	Peptides (Polypeptides)IBA 11/2023 - 01/2019
3	PolymersIBA 11/2023 - 01/2019
2	SolutionsIBA 11/2023 - 10/2023
2	Gefitinib (Iressa)FDA Link 01/2023 - 01/2020
2	Podophyllotoxin (Condylox)FDA LinkGeneric 07/2022 - 05/2022
2	ProdrugsIBA 07/2022 - 05/2022
2	Peptide Initiation Factors (Initiation Factor)IBA 01/2022 - 06/2015
2	Chondroitin Sulfates (Chondroitin Sulfate)IBA 10/2021 - 01/2021
2	Biocompatible Materials (Biomaterials)IBA 10/2021 - 01/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021 - 01/2021
2	Polysaccharides (Glycans)IBA 10/2021 - 01/2021
2	IntegrinsIBA 05/2021 - 01/2019
2	Carmustine (FIVB)FDA Link 01/2020 - 05/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2016
2	Small Interfering RNA (siRNA)IBA 01/2016 - 01/2015
1	diphenyl (biphenyl)IBA 02/2024
1	Taurine FDA Link 01/2024
1	Sincalide FDA Link 01/2024
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023
1	InterferonsIBA 12/2023
1	Mannose (D-Mannose)IBA 12/2023
1	stearic acid (magnesium stearate)FDA LinkGeneric 12/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2023
1	stearylamineIBA 11/2023
1	DisulfidesIBA 11/2023
1	Sunitinib (Sutent)FDA Link 10/2023
1	cadherin 5IBA 10/2023
1	Claudin-4IBA 10/2023
1	AnnexinsIBA 09/2023
1	Messenger RNA (mRNA)IBA 09/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	2-(dimethylamino)ethyl methacrylateIBA 09/2022
1	Immune Checkpoint InhibitorsIBA 07/2022
1	Antineoplastic Agents (Antineoplastics)IBA 05/2022
1	Hypoxia-Inducible Factor 1IBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 10/2021
1	Dextrans (Dextran)FDA Link 10/2021
1	Liposomes (Liposome)IBA 05/2021
1	Phosphates (Orthophosphate)IBA 04/2021
1	Phosphorus (Red Phosphorus)IBA 04/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	GlycosaminoglycansIBA 01/2021
1	3' Untranslated Regions (3' UTR)IBA 01/2021
1	CarbonIBA 05/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	WZ4003IBA 01/2020
1	bromopyruvateIBA 01/2020
1	MethyltransferasesIBA 01/2020

Therapy/Procedure

14	Therapeutics 12/2023 - 01/2016
11	Drug Therapy (Chemotherapy) 11/2023 - 06/2015
4	Immunotherapy 12/2023 - 01/2021
2	Photothermal Therapy 10/2021 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 10/2021 - 01/2021
1	Aftercare (After-Treatment) 10/2023